Logo Image
News
All NewsDosing & Delivery InnovationsPress ReleasesProduct Approvals and Launches
Video
All Video TypesAJMC TVGuidelinesInsightsOnLocationPayer PerspectivesPeer ExchangePost Conference PerspectivesShortsStakeholder Summit
Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
More
Conferences
Conference CoverageConference ListingPost Conference Perspectives
Events
AJMC EventsEvents CalendarInstitute for Value-Based MedicinePatient-Centered Oncology CarePopulation Health RoundtablesWebinars
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Video
  • Podcasts
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Chronic Hand Eczema
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Hepatitis
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Pulmonary Fibrosis
  • Rheumatology
  • Urology
    • Overactive Bladder
  • Women's Health
    • Endometriosis
  • Biosimilars
  • Bispecifics Network
  • Center on Health Equity & Access
  • Digital Health
  • Dosing & Delivery Innovations
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement
|Videos|February 3, 2022

Supporting MRD Availability

Our experts tell us how we can support the availability of MRD for more patients.

Advertisement

Episodes in this series

EP. 1 Explaining Molecular Residual Disease
EP. 1 Explaining Molecular Residual Disease
EP. 2 The Evolution of Circulating Tumor DNA in Oncology
EP. 2 The Evolution of Circulating Tumor DNA in Oncology
EP. 3 MRD Assessments
EP. 3 MRD Assessments
EP. 4 MRD Results and Guiding Treatment Decisions
EP. 4 MRD Results and Guiding Treatment Decisions
EP. 5 MRD and Value-Based Care Models
EP. 5 MRD and Value-Based Care Models
EP. 6 Supporting MRD Availability
Now Playing
EP. 6 Supporting MRD Availability
EP. 7 INSPIRE and IMvigor011 Trials
EP. 7 INSPIRE and IMvigor011 Trials
EP. 8 Potential Changes for MRD in the Future
EP. 8 Potential Changes for MRD in the Future
Advertisement
News Network
|
Video Series
|
Clinical
|
Guiding Appropriate Cancer Treatment with Molecular Residual Disease Testing

Related Content

Advertisement
patient injecting semaglutide | Image Credit: Lana Pietukhova - stock.adobe.com

Semaglutide More Than Doubled Likelihood of MASH Resolution

ByBrooke McCormick
July 28th 2026
liver virus hepatitis | Image credit: bluebay2014 - stock.adobe.com

Why a Landmark Hepatitis D Drug May Not Be Enough on Its Own

BySkylar Jeremias
July 28th 2026
Pills | Image Credit: bukhta79 - stock.adobe.com

Drug Development-to-Reimbursement Timelines Show Little Progress Over a Decade

ByBrooke McCormick
July 27th 2026
Asian elderly patient speaks with doctor | Image credit:  M+Isolation+Photo - stock.adobe.com

Nipocalimab Improves gMG Outcomes Across East Asian Subgroup

ByHabiba Atta
July 27th 2026
Headshot of John Kitchens, MD, on AJMC branded Q&A background

Anti-VEGF Has Hit Its DME Ceiling: John Kitchens, MD

ByLaura Joszt, MA,John Kitchens, MD
July 27th 2026
Advertisement
Advertisement

Trending on AJMC

1

Jeff Hunnicutt to Bring Community Oncology Roots to New Role as Navista COO

2

Contributor: State Leaders Need Real-World Evidence to Integrate Social Care at Scale

3

New MINT Trial Analysis Favors Liberal Transfusion After MI

4

Nipocalimab Improves gMG Outcomes Across East Asian Subgroup

5

Drug Development-to-Reimbursement Timelines Show Little Progress Over a Decade

Brand Logo
  • About
  • Contact
  • Editorial Boards
  • Advertise
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2026 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text